The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea

NCT ID: NCT03232658

Last Updated: 2019-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea (OSA) is a common nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep. Currently, clinical diagnosis of OSA is based on the clinical symptoms, especially excessive daytime sleepiness, and apnea-hypopnea index (AHI) providing a limited overview of the breathing cessation event frequency during the night. Longer obstruction events and deeper desaturations have been suggested to be more harmful than shorter and shallower events and these individual characteristics are completely neglected by conventional and currently used AHI.

The investigators have previously introduced novel diagnostic parameters incorporating the number, duration and morphology of individual obstruction events and shown that they improve the severity estimation of OSA compared to traditional measures. Even though, the novel diagnostic parameters have so far tackled some of shortcomings of AHI, they need to be refined to further increase the accuracy of the OSA severity estimation.

It has been shown that age, body mass index (BMI) and sleeping position are strongly related to the severity OSA. However, it is not thoroughly studied whether the severity of individual obstruction events progress over time (the aging process) and which factors affect to this progression. It is known that OSA patients with similar AHI values, durations of individual breathing cessation events can differ significantly. Longer and deeper events are connected to increased mortality rate in patients with moderate or severe OSA and thus, could be considered to be more detrimental than shorter and shallower ones. However, it has not been thoroughly investigated whether in severe OSA patients with identical AHI values, sleep efficiency or hypertension is related to the severity of individual breathing cessation events.

The investigators planned to explore, whether the individual breathing cessation event severity progress over time and how different confounding factors affect this progression. Furthermore, the correlation of EDS with the individual breathing cessation event severity, sleep structure, and frequency and occurrence of cortical arousals will be investigated. Also, the investigators will explore whether the percentage time of disturbed breathing from total sleep time is related to sleep efficiency or hypertension in severe OSA patients having similar AHI. Moreover, Positional therapy (PT) i.e., the avoidance of the supine posture during sleep is the treatment of choice for Positional Patients (PP) having most of their breathing abnormalities while sleeping supine. Since it is known that apneas/hypopneas are more severe while sleeping supine, this time the investigators will assess the therapeutic value of PT for severe Non Positional patients (NPP).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obstructive sleep apnea (OSA) is a prevalent nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep 1. OSA is connected to cardiovascular disease, increased mortality rate and impairment of quality of life 2-4. Its prevalence has been estimated to be 9-27 % among middle-aged population and the prevalence is expected to increase in the future 5,6.

Currently, the most commonly used diagnostic parameter for OSA is apnea-hypopnea index (AHI) based on number of apneas and hypopneas during sleep, neglecting their durations and also durations and depths of related desaturation events. In adults OSA is diagnosed if patient has 1) AHI≥5 events/h with associated symptoms (e.g. excessive daytime sleepiness (EDS)) or medical or psychiatric disorder (e.g. hypertension or mood disorder) or 2) AHI≥15 events/h 7.

Previously, the investigators have introduced novel parameters called as obstruction severity, obstruction duration, desaturation severity, desaturation duration, and adjusted-AHI incorporating number, duration and morphology of individual obstruction events (i.e. apneas, hypopneas, and oxygen desaturations) 8,9.we have shown that these parameters can enhance the severity estimation of OSA and that the individual breathing cessation event severity is more strongly connected to increased mortality and cardiovascular morbidities than conventional AHI8,10,11. The potential of these parameters to enhance the assessment of severity of OSA has been previously investigated only using ambulatory polygraphic recordings without EEG registration. Therefore, the parameters do not take into account hypopneas followed by arousal (but not desaturation). In addition, parameters do not take into account apneas not followed by desaturation and novel parameters need to be refined to take into account also such events in order to further increase their prognostic value.

It is known that age and body mass index (BMI) are positively related with the prevalence of OSA12,13. Furthermore, AHI is higher and apneas longer in supine position compared to lateral position14-16. However, it is not thoroughly explored whether the severity of individual obstruction events progress over time and which factors affect to this progression.

EDS is a common symptom of OSA and it can be measured in various methods. The most widely used methods are Epworth Sleepiness Scale (ESS) questionnaire which measures subjective sleepiness and Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT) which measure sleepiness objectively. However, the correlation between ESS score and the severity of OSA (i.e. number of obstruction events) have been shown to be poor 17. Furthermore, albeit MSLT and MWT have been shown to have better correlations with daytime functions than ESS their correlations with AHI and arousal index still remainsweak18. Therefore, it needs to be investigated whether the severity of individual breathing cessation events is correlated better with MSLT and MWT and thus, explaining with more accuracy the daytime symptoms.

It has been shown that between patients with identical AHI values, durations of individual apneas and hypopneas and durations, depths, and areas of individual desaturations can differ significantly 19. Longer and deeper obstruction events could be considered to be more harmful than shorter and shallower events as they are linked to increased mortality rate in patients with moderate or severe OSA 8. Nonetheless, it has not been thoroughly investigated whether in severe OSA patients with identical AHI values sleep efficiency or hypertension is related to the severity of individual breathing cessation events and if this relationship is modulated by sleeping position.

Positional therapy (PT), the avoidance of the supine posture during sleep is the treatment of choice for Positional Patients (PP) who have only or most of the apneas/hypopneas while sleeping in the supine posture 22. Non positional patients (NPP) have many apneas/hypopneas while sleeping in both, the supine and the lateral posture. For these patients Continuous Positive Airway Pressure (CPAP) is the treatment of choice, however, many patients have strong difficulties to adhere to CPAP and thus, the investigators would like to assess the therapeutic value of PT for these NNP. Since apneas/hypopneas are more severe while sleeping in the supine than in the lateral posture.15, 16 PT for these patients could represent a valuable treatment. This is an issue that the investigators also want to assess in this project.

In this research project the investigators aim to tackle these shortcomings in the diagnostics of OSA. The main aim is to improve the severity estimation of OSA by further refining the novel parameters for diagnostics of OSA. These improvements to the parameters will be done in order to prevent the harmful consequences of the disease and to be able to target the limited treatment resources to those in the greatest need.

2\. HYPOTHESES AND AIMS

In this research project the investigators tackle the limitations of AHI and refine the novel parameters introduced in our earlier papers. To achieve this, four aims will be undertaken. The first aim is to explore, whether the severity of individual breathing cessations progresses over time and how different confounding factors (e.g. BMI, sleeping position, and gender) affect this progression. The investigators believe that individual event characteristics have a major role in the overall severity of OSA. The current knowledge on the progression of OSA is limited to number of events while the detailed changes in the individual event characteristics has not been thoroughly explored before. This is a major shortcoming as event severity can be considered clinically significant and have been associated with the risk of OSA related mortality and cardiovascular morbidity. The second aim is to improve our recently developed novel parameters to provide even more accurate severity estimation by including more detailed analysis of hypopnea events followed by arousal and apnea events that do not induce desaturations. This more detailed analysis can enhance the estimation of OSA related mortality and incidence of comorbidities and improve the discrimination of patients needed to be treated but it can also help clinicians to choose best individualized treatment method for each patient. The third aim of the research project is to evaluate the correlation of excessive daytime sleepiness (EDS) with the individual breathing cessation event severity, sleep structure, and frequency and occurrence of cortical arousals. As EDS is a major problem reducing the quality of life, finding effective measures to recognize factors behind EDS could aid to enhance the treatment of these patients and improvement of their life quality. The fourth aim is to explore whether the percentage time of disturbed breathing from total sleep time is related to sleep efficiency or hypertension in severe OSA patients having similar AHI values and whether this percentage alters depending on confounding factors (e.g. BMI, hypertension, and proportion of supine sleep). More detailed characterization of severe OSA patients could aid the clinicians to recognize the patients with most urgent need for effective treatment.

The fifth aim is to assess the therapeutic value of positional therapy (PT) for severe NPP. This assessment is of interest since many severe OSA patients that should be treated with CPAP are not been treated due to the difficulties to adhere to CPAP treatment. This behavioral treatment could represent a partial solution until these patients lose weight, consider surgery (ENT or bariatric) or the use of dental appliance or give to CPAP another chance.

It is important to note that by losing weight NPP may become PP 23 and thus, PT could represent no a partial but a more radical solution.

2\. RESEARCH PLAN AND METHODS

The planned research includes five work packages designed to enable reaching the project aims.

Work package I: Progression of individual obstruction events over time - retrospective follow-up study In this package,we will explore how the duration of individual apnea and hypopnea events and duration, depth and area of individual desaturation events progress over time. It will be investigated how different confounding factors (e.g. age, BMI, sleeping position and gender) affect the progression of the individual breathing cessation event severity. This package is based on polysomnographic (PSG) recordings of about 400 patients with suspected OSA recorded with Embla (Natus Medical Incorporated, Pleasanton, CA, USA) or Rembrandt (Natus Medical Incorporated, Pleasanton, CA, USA) devices and analyzed using RemLogic software at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center, Raanana, Israel. For all patients, two - three PSG recordings were conducted at different time points, at baseline, and after 3, 5, 10 years or more. These polygraphic recordings were analyzed in conformity with the standard respiratory rules specified by AASM and based on clinical practice in Lowenstein Hospital at the time of analysis. Based on the analyzed recordings, the severity of individual obstruction events will be calculated using custom-made MATLAB (Matlab R2014b, MathWorks Inc., Natick, MA, USA) functions. Severity of individual obstruction events will be compared between the different time points for each patient and in a group level. Grouping of the patients will be done based on the confounding factors (e.g. patients' BMI, gender, sleeping position, AHI, and age).

Work package II: Optimization of the diagnostic parameters of OSA which incorporates the severity of individual breathing cessation events In this package, the novel parameters will be further refined by adding features to also include apneas not followed by desaturations and hypopneas followed by arousal (but not desaturation). Furthermore, the aim is to evaluate whether apneas should be given more weight than hypopneas while estimating the overall severity of OSA. In this package, in-laboratory PSG recordings (n=7540) including EEG conducted and analyzed at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center for the patients with clinical suspicion of OSA will be studied. The basic anthropometric data and information on mortality and co-morbidities will be also collected. All recordings were analyzed according the standard respiratory rules defined by AASM and based on clinical practice in Lowenstein Hospital. Novel parameters and severity of individual obstruction events will be calculated using custom-made MATLAB functions. The calculated severity indexes based on enhanced and the original obstruction severity parameters will be compared with incidence of OSA related mortality and co-morbidities.

The information on mortality, cause of death and co-morbidities hopefully will be obtained from the Ministry of Health.

Work package III: Effect of severity of individual obstruction events on excessive daytime sleepiness In this package, the investigators investigate the correlation between the severity of individual breathing cessation events and excessive daytime sleepiness measured with objective means (i.e. Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT)). Furthermore, it will be studied which information obtained from PSG recordings (e.g. frequency and duration of cortical arousal, sleep structure or severity of individual obstruction events) is best correlated with excessive daytime sleepiness and therefore, would be beneficial to take into account while estimating the severity of OSA. Clinical in-laboratory PSG recordings (n=3000) of patients with suspected OSA, conducted and analyzed at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center with the Embla devices and RemLogic software, will be used. The values of the novel parameters and the severity of individual obstruction events will be calculated using custom-made MATLAB functions and their correlation on results of objective tests measuring excessive daytime sleepiness (i.e. MSLT and MWT) will be investigated.

Work package IV: Differences in severity of individual obstruction events between patients having severe OSA In this package, the severe OSA patients will be matched by AHI and the percentage time of disturbed breathing from total sleep time will be compared between these patients. The patient population consists of 463 patients diagnosed to have severe OSA after full overnight PSG recording conducted at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center. It will be studied whether the percentage time of disturbed breathing from total sleep time differs between the patients having similar AHI and whether it is related to different outcome measures (e.g. hypertension and sleep efficiency). Furthermore, it will be investigated whether this percentage is modulated by different confounding factors (e.g. gender, BMI, and sleeping position).

Work package V: The assessment of the therapeutic value of Positional Therapy for severe Non Positional Patients (NPP) In this package the investigators we will assess the therapeutic value of Positional Therapy (PT) i.e., the avoidance of the supine posture during sleep, as a treatment alternative for severe Non Positional Patients (NPP) who failed to adhere to Continuous Positive Airway Pressure (CPAP). The patient population consists of the same 463 patients diagnosed to have severe OSA after full overnight PSG recording conducted at the Sleep Disorders Unit, Loewenstein Hospital - Rehabilitation Center. In this group of patients the investigators will assess the effect of sleeping only in the lateral posture (PT) and the assessment of the severity of the disease will be calculated according to conventional and new methods developed previously by our research group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Good technical quality of polysomnographic (PSG) records

Exclusion Criteria

* Bad technical quality of polysomnographic (PSG) records
Minimum Eligible Age

16 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Eastern Finland

OTHER

Sponsor Role collaborator

Seinajoki Central Hospital

OTHER

Sponsor Role collaborator

Kuopio University Hospital

OTHER

Sponsor Role collaborator

Princess Alexandra Hospital, Brisbane, Australia

OTHER

Sponsor Role collaborator

Loewenstein Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Arie Oksenberg

Arie Oksenberg, PhD- Director Sleep Disorders Unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arie Oksenberg, PhD

Role: PRINCIPAL_INVESTIGATOR

Loewenstein Hospital - Rehabilitation Center, Raanana, Israel

Juha Töyräs, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Eastern Finland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sleep Disorders Centre, Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital, Australia

Brisbane, , Australia

Site Status ENROLLING_BY_INVITATION

Department of Applied Physics, University of Eastern Finland

Kuopio, , Finland

Site Status ENROLLING_BY_INVITATION

Department of Clinical Neurophysiology, Seinäjoki Central Hospital,

Seinäjoki, , Finland

Site Status ENROLLING_BY_INVITATION

Sleep Disorders Unit - Loewenstein Hospital

Raanana, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Australia Finland Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Arie Oksenberg, PhD

Role: CONTACT

+972 544755738

Juha Töyräs, Professor

Role: CONTACT

+358 40 3552026

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arie Oksenberg, PhD

Role: primary

+972544755738

Natan Gadoth, MD

Role: backup

+972546229346

References

Explore related publications, articles, or registry entries linked to this study.

Oksenberg A, Gadoth N, Toyras J, Leppanen T. Prevalence and characteristics of positional obstructive sleep apnea (POSA) in patients with severe OSA. Sleep Breath. 2020 Jun;24(2):551-559. doi: 10.1007/s11325-019-01897-1. Epub 2019 Jul 20.

Reference Type DERIVED
PMID: 31325020 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0006-17-LOE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychological Aspects in OSA
NCT06292325 COMPLETED